Taeko Ishii
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study.
Journal: Modern rheumatology
Published: March 04, 2024
Efficacy and safety of baricitinib in Japanese patients with autoinflammatory type I interferonopathies (NNS/CANDLE, SAVI, And AGS).
Journal: Pediatric rheumatology online journal
Published: November 10, 2022
Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance.
Journal: Modern rheumatology
Published: May 19, 2022
Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.
Journal: BMC pulmonary medicine
Published: May 09, 2022
Real-world clinical outcomes of treatment with casirivimab-imdevimab among patients with mild-to-moderate coronavirus disease 2019 during the Delta variant pandemic.
Journal: International journal of medical sciences
Published: January 16, 2022
Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare Database.
Journal: Annals of clinical epidemiology
Published: April 24, 2021
Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.
Journal: Modern rheumatology
Published: February 21, 2019
Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis.
Journal: RMD open
Published: January 07, 2019
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment.
Journal: The Journal of rheumatology
Published: July 01, 2018
Self-monitoring of urinary salt excretion as a method of salt-reduction education: a parallel, randomized trial involving two groups.
Journal: Public health nutrition
Published: February 21, 2018
Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.
Journal: Modern rheumatology
Published: November 15, 2017
Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study.
Journal: Modern rheumatology
Published: April 26, 2017
Last Updated: 09/26/2026